1药网 (YI) Stock Surges Amid Financial Performance Concerns

Author's Avatar
Dec 20, 2024

1药网 (YI, Financial) experienced a notable stock price surge of 8.32%, reaching $0.815 with a trading volume of 51,431 shares. The stock's turnover rate was 0.06% and its amplitude was 9.33%. Recent financial reports reveal 1药网's revenue at $502 million, a net loss of $2.39 million, and earnings per share of -$0.03. The company has a gross profit of $29.38 million and a negative P/E ratio of -1.88. Currently, there are no institutional ratings for the stock.

In the medical sales sector, 1药网 showed significant growth alongside Zynex, Inc. and Akso Health Group. Akso Health Group had the highest amplitude at 15.97%. 1药网 operates an integrated online and offline platform in China, with its B2B segment contributing the majority of its revenue.

A recent report questioned the rationality of 1药网's market valuation at $67.68 million, given its $2 billion revenue and consistent quarterly operating profits.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.